Liberty One Investment Management LLC Raises Position in The Clorox Company $CLX

Key Points

• Liberty One Investment Management LLC increased its position in The Clorox Company by 11.5% during Q2, now holding 224,873 shares worth approximately $27 million.
• Clorox has reported earnings of $2.87 per share, surpassing analysts' expectations of $2.24, with a revenue of $1.99 billion for the same quarter.
• Several analysts have downgraded their price targets for Clorox, with an average target now set at $130.20, while the stock has a current market cap of $14.56 billion.

Liberty One Investment Management LLC increased its holdings in The Clorox Company (NYSE:CLX - Free Report) by 11.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 224,873 shares of the company's stock after purchasing an additional 23,132 shares during the quarter. Clorox accounts for 2.7% of Liberty One Investment Management LLC's investment portfolio, making the stock its 14th biggest position. Liberty One Investment Management LLC owned 0.18% of Clorox worth $27,000,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the business. Triton Financial Group Inc purchased a new position in Clorox in the 2nd quarter worth $869,000. Journey Advisory Group LLC raised its position in Clorox by 22.1% in the 2nd quarter. Journey Advisory Group LLC now owns 1,991 shares of the company's stock worth $239,000 after purchasing an additional 360 shares during the period. Bogart Wealth LLC raised its position in Clorox by 289.5% in the 2nd quarter. Bogart Wealth LLC now owns 370 shares of the company's stock worth $44,000 after purchasing an additional 275 shares during the period. Canvas Wealth Advisors LLC raised its position in Clorox by 190.5% in the 2nd quarter. Canvas Wealth Advisors LLC now owns 29,548 shares of the company's stock worth $3,760,000 after purchasing an additional 19,377 shares during the period. Finally, Stephens Inc. AR raised its position in Clorox by 32.4% in the 2nd quarter. Stephens Inc. AR now owns 3,778 shares of the company's stock worth $454,000 after purchasing an additional 924 shares during the period. Hedge funds and other institutional investors own 78.53% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on CLX shares. Citigroup decreased their price objective on shares of Clorox from $135.00 to $130.00 and set a "neutral" rating on the stock in a research report on Wednesday, October 8th. Barclays decreased their price objective on shares of Clorox from $118.00 to $112.00 and set an "underweight" rating on the stock in a research report on Tuesday, September 30th. JPMorgan Chase & Co. decreased their price objective on shares of Clorox from $135.00 to $127.00 and set a "neutral" rating on the stock in a research report on Friday, October 10th. Zacks Research upgraded shares of Clorox from a "strong sell" rating to a "hold" rating in a research report on Monday, September 29th. Finally, The Goldman Sachs Group decreased their price objective on shares of Clorox from $115.00 to $110.00 and set a "sell" rating on the stock in a research report on Wednesday, October 1st. One research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Clorox currently has an average rating of "Reduce" and an average price target of $130.20.

Clorox Price Performance

Shares of NYSE CLX opened at $119.60 on Tuesday. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The company's 50-day moving average is $121.56 and its 200 day moving average is $127.42. The stock has a market capitalization of $14.56 billion, a P/E ratio of 18.34, a P/E/G ratio of 0.99 and a beta of 0.52.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion for the quarter, compared to analysts' expectations of $1.94 billion. During the same quarter in the previous year, the company earned $1.82 earnings per share. Clorox's quarterly revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox's dividend payout ratio is 76.07%.

Insiders Place Their Bets

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the company's stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.63% of the company's stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.